Tokyo, Aug. 4 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058674) titled 'Impact of Resting Full-cycle Ratio on Clinical Outcomes in Patients on Hemodialysis' on Aug. 4.
Study Type:
Observational
Primary Sponsor:
Institute - Juntendo University
Condition:
Condition - Coronary artery disease on hemodialysis
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To evaluate prognostic impact of resting full-cycle ratio (RFR) on clinical outcomes in patients on hemodialysis
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - 20
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients with age 20 years or older at the time of enrollment
Patients on hemodialysis
Patients with or suspected coronary artery disease
Patients with RFR measurement
Key exclusion criteria - Patients with acute myocardial infarction
Patients with hemodynamic instability
Patients with decompensated heart failure
Patients treated by coronary revascularization for target vessel based on RFR
Patients with RFR measurement for coronary artery bypass graft
Patients with a life expectancy of 12 months or less
Others who are judged to be inappropriate as research subjects by the principal investigator
Target Size - 260
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 06 Month 09 Day
Anticipated trial start date - 2025 Year 09 Month 01 Day
Last follow-up date - 2027 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067092
Disclaimer: Curated by HT Syndication.
